Treace Medical Concepts TMCI reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Treace Medical Concepts missed estimated earnings by -11.0%, reporting an EPS of $-0.1 versus an estimate of $-0.09.
Revenue was up $12.44 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 38.0% drop in the share price the next day.
Here's a look at Treace Medical Concepts's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.26 | -0.24 | -0.23 | -0.14 |
EPS Actual | -0.28 | -0.20 | -0.23 | -0.08 |
Revenue Estimate | 42.05M | 40.85M | 39.24M | 44.75M |
Revenue Actual | 40.76M | 41.95M | 42.20M | 49.77M |
To track all earnings releases for Treace Medical Concepts visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.